NT-proBNP in heart failure: therapy decisions and monitoring.
about
Rationale, design and conduct of a randomised controlled trial evaluating a primary care-based complex intervention to improve the quality of life of heart failure patients: HICMan (Heidelberg Integrated Case Management).Fatigue with systolic heart failureThe role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T.Elderly dialysis patients: analysis of factors affecting long-term survival in 4-year prospective observationVariability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study.Simultaneous predictive value of NT-proBNP and CA-125 in patients newly diagnosed with advanced heart failure: preliminary resultsCardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay.Optimizing treatment and outcomes in acute heart failure: beyond initial triage.Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in?In-hospital and long-term outcomes of congestive heart failure: Predictive value of B-type and amino-terminal pro-B-type natriuretic peptides and their ratio.Cirrhotic cardiomyopathy: Implications for liver transplantation.A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.Effects of treatment with epoetin beta on outcomes in patients with anaemia and chronic heart failure.Natriuretic peptides for heart failure. Fashionable? Useful? Necessary?Association between serum level of ubiquinol and NT-proBNP, a marker for chronic heart failure, in healthy elderly subjects.Serum NT-proBNP concentrations in the early phase do not predict the severity of systolic or diastolic left ventricular dysfunction among patients with ST-elevation acute myocardial infarction.Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients.
P2860
Q33294995-9381F408-0DB5-4BCB-BFA1-5FEE9556DC67Q33885398-6D1064D3-B0F3-461C-AD25-B02584F62E6DQ34580385-380807EC-32EE-4C24-97CB-B5AC5EF667B4Q35981517-8061B409-784E-420D-8E43-A0C4F29D8E25Q36014073-FE2CD698-4B90-4180-9C5A-BE9C6A0DDFB8Q36286287-12D636B2-75FE-45C4-A189-8E1E90C099EDQ36350919-FDC8D55D-C652-4EFD-99BC-D59D10B65A8EQ36442407-F3FA407E-74FC-4B02-857D-30EE686702AEQ36499953-8457A89B-B9B4-4A49-9323-FB6F12C18F0CQ38083745-B0F2B51A-CF37-483B-8C7A-D7741CDECB3CQ38623581-2B040DE4-83C1-4951-A9A5-8BA043E9AF7DQ39240722-EA74BC7D-81DA-47F1-A106-1ADB919598BFQ45091868-C721847E-E769-4068-A7E5-6CE8082AC439Q45110909-EDB27913-EC23-4F8B-940D-B598654BC3B7Q48030240-638CED6F-D8AD-4A1B-9D65-B01E35C9BFD3Q48303041-232B5A16-33D3-4F8E-BFE1-CBC95A969B02Q48305238-4F505136-6E25-40C3-B386-CEC7431A1184Q48635264-F102DF13-1558-4517-8C54-05EA8281B6E7
P2860
NT-proBNP in heart failure: therapy decisions and monitoring.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
NT-proBNP in heart failure: therapy decisions and monitoring.
@ast
NT-proBNP in heart failure: therapy decisions and monitoring.
@en
type
label
NT-proBNP in heart failure: therapy decisions and monitoring.
@ast
NT-proBNP in heart failure: therapy decisions and monitoring.
@en
prefLabel
NT-proBNP in heart failure: therapy decisions and monitoring.
@ast
NT-proBNP in heart failure: therapy decisions and monitoring.
@en
P2860
P1476
NT-proBNP in heart failure: therapy decisions and monitoring
@en
P2093
Mark Richards
P2860
P304
P356
10.1016/J.EJHEART.2004.01.003
P577
2004-03-01T00:00:00Z